We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
+2.39%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$18.8B
AUM Growth
–
Cap. Flow
+$18.6B
Cap. Flow
% of AUM
98.77%
Top 10 Holdings %
Top 10 Hldgs %
14.87%
Holding
1,277
New
1,254
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$355M |
| 2 |
Apple
AAPL
|
+$344M |
| 3 |
Chevron
CVX
|
+$323M |
| 4 |
JPMorgan Chase
JPM
|
+$296M |
| 5 |
ExxonMobil
XOM
|
+$285M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.45% |
| 2 | Financials | 12.81% |
| 3 | Technology | 12.27% |
| 4 | Energy | 10.62% |
| 5 | Miscellaneous | 9.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MANT
676
DELISTED
Mantech International Corp
MANT
| $2.06M | 0.01% |
+78,900
| New | +$2.09M |
|
677
Olin
OLN
$1.95B
| $2.04M | 0.01% |
+85,300
| New | +$2.09M |
|
|
ALR
678
DELISTED
Alere Inc
ALR
| $2.04M | 0.01% |
+83,200
| New | +$2.15M |
|
|
ESND
679
DELISTED
Essendant Inc.
ESND
| $2.02M | 0.01% |
+60,300
| New | +$2.08M |
|
|
QCOR
680
DELISTED
QUESTCOR PHARMA INC
QCOR
| $2.02M | 0.01% |
+44,457
| New | +$1.58M |
|
681
AAR Corp
AIR
$4.67B
| $2.02M | 0.01% |
+91,800
| New | +$1.77M |
|
|
CVSA
682
Covista Inc
CVSA
$4.3B
| $2.01M | 0.01% |
+64,900
| New | +$1.95M |
|
683
Sherwin-Williams
SHW
$78.5B
| $2.01M | 0.01% |
+34,170
| New | +$2.06M |
|
684
Hanover Insurance
THG
$8.11B
| $2.01M | 0.01% |
+41,100
| New | +$2.02M |
|
|
PARA
685
DELISTED
Paramount Global Class B
PARA
| $1.99M | 0.01% |
+40,800
| New | +$1.86M |
|
686
Intuitive Surgical
ISRG
$133B
| $1.98M | 0.01% |
+35,100
| New | +$1.93M |
|
687
Abercrombie & Fitch
ANF
$5.74B
| $1.97M | 0.01% |
+43,600
| New | +$2.15M |
|
688
Tenaris
TS
$28.6B
| $1.96M | 0.01% |
+48,736
| New | +$2.04M |
|
|
LXK
689
DELISTED
Lexmark Intl Inc
LXK
| $1.96M | 0.01% |
+64,200
| New | +$1.89M |
|
690
New York Times
NYT
$11.6B
| $1.96M | 0.01% |
+176,900
| New | +$1.74M |
|
|
DYAX
691
DELISTED
DYAX CORPORATION
DYAX
| $1.93M | 0.01% |
+558,800
| New | +$1.82M |
|
692
Molson Coors Class B
TAP
$7.32B
| $1.92M | 0.01% |
+40,200
| New | +$2.03M |
|
693
Trinity Industries
TRN
$2.24B
| $1.92M | 0.01% |
+138,900
| New | +$2.03M |
|
|
ETP
694
DELISTED
Energy Transfer Partners, L.P.
ETP
| $1.92M | 0.01% |
+60,000
| New | +$1.88M |
|
|
GRFS
695
Grifois
GRFS
$5.01B
| $1.92M | 0.01% |
+134,536
| New | +$1.89M |
|
|
DISH
696
DELISTED
DISH Network Corp.
DISH
| $1.91M | 0.01% |
+44,974
| New | +$1.75M |
|
|
PDLI
697
DELISTED
PDL BioPharma, Inc.
PDLI
| $1.91M | 0.01% |
+247,300
| New | +$1.93M |
|
|
UNT
698
DELISTED
UNIT Corporation
UNT
| $1.91M | 0.01% |
+44,800
| New | +$1.97M |
|
699
Ziff Davis
ZD
$2.03B
| $1.89M | 0.01% |
+51,210
| New | +$1.79M |
|
700
Eldorado Gold
EGO
$10.5B
| $1.89M | 0.01% |
+61,315
| New | +$2.26M |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Axa, which disclosed 1,277 positions worth $18.8B. Its ten largest holdings account for 15% of the portfolio.
Its largest position is Pfizer: 12,852,527 shares worth $342M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, followed by Financials and Technology.
- Axa's largest Q2 2013 buy was Pfizer: 12,852,527 shares worth $342M.
- Axa's ten largest holdings make up 15% of its $18.8B portfolio in Q2 2013.
- Axa disclosed 1,277 positions in Q2 2013, its first 13F filing on record.
Based on Axa's 13F filing for Q2 2013, filed 12 Aug 2013.